聚类分析识别结节病性葡萄膜炎患者的多维表型
该回顾性队列纳入2003年12月至2020年12月里昂的299例结节病性葡萄膜炎患者,采用层次聚类分析识别出3个表型:年轻非白种人急性前葡萄膜炎伴全身表现、中年白种人慢性全葡萄膜炎孤立起病、中年白种人孤立起病但眼别分布均匀;三组完全视力恢复率分别为84.1%、45.3%和55.3%。
要点
- 年轻非白种人患者多表现为急性前葡萄膜炎伴全身表现,完全视力恢复率84.1%。
- 中年白种人慢性全葡萄膜炎患者完全视力恢复率45.3%,预后较差。
- 另一中年白种人孤立性葡萄膜炎组完全视力恢复率55.3%,预后接近慢性全葡萄膜炎组。
核心结论
- 该回顾性研究提示结节病性葡萄膜炎患者存在多种表型,其进展和预后不同。
- 需进一步研究确定可解释这些结果的遗传和环境因素。
研究设计与样本
- 回顾性队列研究,纳入2003年12月至2020年12月里昂连续就诊的活检证实、疑似或很可能结节病性葡萄膜炎患者299例。
- 全身结节病按Abad改良标准诊断,葡萄膜炎按葡萄膜炎命名标准化分类,采用层次聚类分析识别表型。
主要发现
- 第1类为年轻非白种人患者,急性葡萄膜炎占75.3%、前葡萄膜炎占55.6%、全身表现占87.8%,需口服糖皮质激素者占75.3%、免疫抑制治疗者占17.2%,完全视力恢复者占84.1%。
- 第2类为中年白种人患者,慢性葡萄膜炎占91.7%、全葡萄膜炎占79.5%、诊断时孤立性葡萄膜炎占74.8%,需全身糖皮质激素者占74.0%、免疫抑制治疗者占9.8%,完全视力恢复者占45.3%。
- 第3类为中年白种人患者,无慢性或急性优势,诊断时孤立性葡萄膜炎占81.4%,需糖皮质激素者占54.1%、免疫抑制治疗者占13.1%,完全视力恢复者占55.3%。
关键数值与推荐
- 共识别3个聚类:第1类年轻非白种人急性前葡萄膜炎伴全身表现,完全视力恢复84.1%。
- 第2类中年白种人慢性全葡萄膜炎孤立起病,完全视力恢复45.3%。
- 第3类中年白种人孤立起病、眼别分布均匀,完全视力恢复55.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出该研究为回顾性研究,提示存在多种表型。
- 原文结论指出需进一步研究确定可解释这些结果的遗传和环境因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify multidimensional phenotypes of sarcoid uveitis patients. DESIGN: Retrospective cohort. METHODS: Consecutive patients with biopsy-proven, presumed, or probable sarcoid uveitis between December 2003 and December 2020 in Lyon were recruited. Data were collected from the clinical notes, and consisted in laboratory and imaging findings, systemic treatments and outcome. Systemic sarcoidosis was diagnosed according to the Abad's modified criteria and uveitis was classified according to the Standardization of Uveitis Nomenclature. A hierarchical cluster analysis was performed. The main outcome measure was identification of different phenotypes of sarcoid uveitis patients. RESULTS: A total of 299 patients were included. Three clusters were identified: (1) younger non-Caucasian patients who presented acute (75.3%), anterior (55.6%) uveitis, and systemic manifestations (87.8%), requiring oral corticosteroids (75.3%) along with immunosuppressive therapy (17.2%) and who were more prone to experience complete visual recovery (84.1%); (2) middle-aged Caucasian patients who presented chronic (91.7%), panuveitis (79.5%), and isolated uveitis at diagnosis (74.8%), requiring systemic treatment with corticosteroids (74.0%) but less frequently immunosuppressive therapy (9.8%) and a worse prognosis (45.3% complete visual recovery); and (3) middle-aged Caucasian patients, without preferential chronic or acute uveitis, isolated uveitis at diagnosis (81.4%), more homogenous in terms of eye involvement repartition, requiring less corticosteroids or immunosuppressive therapy (respectively 54.1% and 13.1%) and having a prognosis close to cluster 2 patients (55.3% complete visual recovery). CONCLUSIONS: This retrospective study suggested the existence of several phenotypes of sarcoid uveitis patients with different progressions and prognoses. Further studies are needed to determine the genetic and environmental factors that could explain these results.
引用
- Fermon C, El-Jammal T, Kodjikian L, et al. Identification of Multidimensional Phenotypes Using Cluster Analysis in Sarcoid Uveitis Patients. Am J Ophthalmol. 2022. PMID: 35752321. doi:10.1016/j.ajo.2022.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。